A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone to Delay Cardiac Repolarization in Healthy Female Volunteers: A Thorough QT/QTc Study

Trial Profile

A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone to Delay Cardiac Repolarization in Healthy Female Volunteers: A Thorough QT/QTc Study

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs Elcometrine (Primary) ; Moxifloxacin
  • Indications Menopausal syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 27 May 2016 Status changed from recruiting to completed.
    • 16 Apr 2015 Planned End Date changed from 1 Jan 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov.
    • 16 Apr 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top